Dudediligence.

Artiva Biotherapeutics, Inc

ARTVNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24
Net income, by quarter
−$17.5MSep ’24−$16.1MDec ’24−$20.3MMar ’25−$21.3MJun ’25−$21.5MSep ’25−$20.8MDec ’25−$23.5MMar ’26−$25.0MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$33.5M$251,000$0.00
Operating incomenone on file−$30.7M−$67.3M−$89.8M
Net incomenone on file−$28.7M−$65.4M−$83.9M
Operating cash flownone on file−$47.4M−$55.0M−$76.8M
Free cash flownone on file−$50.7M−$55.7M−$79.3M
Cash$102.8M$53.5M$40.2M$26.7M
Shares outstandingnone on file802.7K424.0K424.0K